Susan Bobulsky
Chief Commercial Officer, MRD · 5 filings · Latest: Jun 25, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | SUSAN BOBULSKY | — | Jul 1, 2026 | Proposed Sale | $21.45 | 487 | $10.4K | — | |
ADPT | Susan Bobulsky | Chief Commercial Officer, MRD | Jun 25, 2026 | Sale | $20.50 | 5,000 | $102.5K | 406,775 | |
ADPT | SUSAN BOBULSKY | — | Jun 25, 2026 | Proposed Sale | $19.34 | 5,000 | $96.7K | — | |
ADPT | Susan Bobulsky | Chief Commercial Officer, MRD | Jun 11, 2026 | Sale | $19.00 | 5,000 | $95.0K | 411,775 | |
ADPT | SUSAN BOBULSKY | — | Jun 11, 2026 | Proposed Sale | $17.07 | 5,000 | $85.3K | — | |
ADPT | Susan Bobulsky | Chief Commercial Officer, MRD | Jun 4, 2026 | Sale | $18.00 | 11,000 | $198.0K | 416,775 | |
ADPT | SUSAN BOBULSKY | — | Jun 4, 2026 | Proposed Sale | $15.99 | 11,000 | $175.9K | — | |
ADPT | BOBULSKY SUSAN | — | Mar 11, 2026 | Proposed Sale | $14.52 | 41,338 | $600.2K | — | |
ADPT | Susan Bobulsky | Chief Commercial Officer, MRD | Mar 11, 2026 | Sale | $13.17 | 41,338 | $544.4K | 427,775 |